Cargando…
Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are inflammatory rheumatic diseases that may modify body composition. Adipose tissue has the ability to release a wide range of products involved in physiologic functions, but also in various pathological processes, including the inflammatory...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861781/ https://www.ncbi.nlm.nih.gov/pubmed/24379815 http://dx.doi.org/10.3389/fimmu.2013.00453 |
_version_ | 1782295685324865536 |
---|---|
author | Toussirot, Éric Grandclément, Émilie Gaugler, Béatrice Michel, Fabrice Wendling, Daniel Saas, Philippe Dumoulin, Gilles |
author_facet | Toussirot, Éric Grandclément, Émilie Gaugler, Béatrice Michel, Fabrice Wendling, Daniel Saas, Philippe Dumoulin, Gilles |
author_sort | Toussirot, Éric |
collection | PubMed |
description | Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are inflammatory rheumatic diseases that may modify body composition. Adipose tissue has the ability to release a wide range of products involved in physiologic functions, but also in various pathological processes, including the inflammatory/immune response. RA and AS are both associated with the development of cardiovascular complications. It is has been established that central/abdominal, and particularly intra-abdominal or visceral adiposity is closely linked to cardiovascular events. Thus, in this study, we aimed to evaluate the body composition of patients with RA or AS compared to healthy controls (HC), with a special emphasis on the visceral region. In parallel, we measured adipose products or adipokines, namely leptin, adiponectin and its high molecular weight (HMW) isoform, resistin, and ghrelin, a gastric peptide that plays a role in energetic balance. The homeostasis model assessment for insulin resistance (HOMA-IR) and atherogenic index were used to evaluate cardiovascular risk. One hundred and twelve subjects were enrolled (30 patients with RA, 31 with AS, and 51 HC). Body composition was measured using dual-energy X-ray absorptiometry to determine total fat mass and lean mass, adiposity, fat in the android and gynoid regions, and visceral fat. Patients and HC did not differ in terms of body mass index. On the contrary, adiposity was increased in RA (p = 0.01) while visceral fat was also increased, but only in women (p = 0.01). Patients with AS tended to have lower total fat mass (p = 0.07) and higher lean mass compared to HC (p = 0.07). Leptin and leptin/fat mass were decreased in male patients with AS (p < 0.01), while total adiponectin and the ratio of HMW to total adiponectin were both increased in RA (p < 0.01). There were no changes in serum resistin and ghrelin in any group of patients. HOMA-IR and the atherogenic index were not modified in RA and AS. These results confirm that body composition was altered in RA and AS, affecting distinct soft tissue compartments. The effect of the increased visceral adipose tissue on cardiovascular risk is presumably attenuated by the favorable cardiometabolic profile in women with RA, as suggested by the normal HOMA-IR and atherogenic index. |
format | Online Article Text |
id | pubmed-3861781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-38617812013-12-30 Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study Toussirot, Éric Grandclément, Émilie Gaugler, Béatrice Michel, Fabrice Wendling, Daniel Saas, Philippe Dumoulin, Gilles Front Immunol Immunology Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are inflammatory rheumatic diseases that may modify body composition. Adipose tissue has the ability to release a wide range of products involved in physiologic functions, but also in various pathological processes, including the inflammatory/immune response. RA and AS are both associated with the development of cardiovascular complications. It is has been established that central/abdominal, and particularly intra-abdominal or visceral adiposity is closely linked to cardiovascular events. Thus, in this study, we aimed to evaluate the body composition of patients with RA or AS compared to healthy controls (HC), with a special emphasis on the visceral region. In parallel, we measured adipose products or adipokines, namely leptin, adiponectin and its high molecular weight (HMW) isoform, resistin, and ghrelin, a gastric peptide that plays a role in energetic balance. The homeostasis model assessment for insulin resistance (HOMA-IR) and atherogenic index were used to evaluate cardiovascular risk. One hundred and twelve subjects were enrolled (30 patients with RA, 31 with AS, and 51 HC). Body composition was measured using dual-energy X-ray absorptiometry to determine total fat mass and lean mass, adiposity, fat in the android and gynoid regions, and visceral fat. Patients and HC did not differ in terms of body mass index. On the contrary, adiposity was increased in RA (p = 0.01) while visceral fat was also increased, but only in women (p = 0.01). Patients with AS tended to have lower total fat mass (p = 0.07) and higher lean mass compared to HC (p = 0.07). Leptin and leptin/fat mass were decreased in male patients with AS (p < 0.01), while total adiponectin and the ratio of HMW to total adiponectin were both increased in RA (p < 0.01). There were no changes in serum resistin and ghrelin in any group of patients. HOMA-IR and the atherogenic index were not modified in RA and AS. These results confirm that body composition was altered in RA and AS, affecting distinct soft tissue compartments. The effect of the increased visceral adipose tissue on cardiovascular risk is presumably attenuated by the favorable cardiometabolic profile in women with RA, as suggested by the normal HOMA-IR and atherogenic index. Frontiers Media S.A. 2013-12-13 /pmc/articles/PMC3861781/ /pubmed/24379815 http://dx.doi.org/10.3389/fimmu.2013.00453 Text en Copyright © 2013 Toussirot, Grandclément, Gaugler, Michel, Wendling, Saas, Dumoulin and CBT-506. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Toussirot, Éric Grandclément, Émilie Gaugler, Béatrice Michel, Fabrice Wendling, Daniel Saas, Philippe Dumoulin, Gilles Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study |
title | Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study |
title_full | Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study |
title_fullStr | Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study |
title_full_unstemmed | Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study |
title_short | Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study |
title_sort | serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. a comparative study |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861781/ https://www.ncbi.nlm.nih.gov/pubmed/24379815 http://dx.doi.org/10.3389/fimmu.2013.00453 |
work_keys_str_mv | AT toussiroteric serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy AT grandclementemilie serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy AT gauglerbeatrice serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy AT michelfabrice serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy AT wendlingdaniel serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy AT saasphilippe serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy AT dumoulingilles serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy AT serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy |